News Related to Sublingual Immunotherapy

Related coverage linked through entity extraction aliases.

Needle-Free Allergy Therapy and House Dust Mite Treatment Markets Forecast Strong Growth

Apr 17, 2026

Needle-free allergy therapy is forecast to expand through 2035 as self-administered options gain share. House dust mite allergy treatment is projected to grow from $3.18 billion in 2025 to $8.75 billion by 2033.

Allergic Rhinitis Shows Dual Effect on COVID-19 Symptoms; Sublingual Immunotherapy Alters Outcomes

Mar 10, 2026

Allergic rhinitis demonstrates both protective and risk associations with COVID-19 symptoms, while sublingual immunotherapy modifies respiratory and fever outcomes in patients with the condition.